Press Releases

Company News
View Summary Acura Pharmaceuticals to Host Second Quarter 2014 Financial Results Conference Call on August 5, 2014
Jul 24, 2014
PDF 11.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals Provides Update on Its Abuse Deterrent Hydrocodone/Acetaminophen Combination Drug
May 27, 2014
PDF 16.1 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Settlement of Patent Litigation With Sandoz Inc.
May 21, 2014
PDF 16.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Settlement of Patent Litigation With Ranbaxy Inc.
May 8, 2014
PDF 15.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces First Quarter 2014 Financial Results
May 5, 2014
PDF 20.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host First Quarter 2014 Financial Results Conference Call on May 6, 2014
Apr 28, 2014
PDF 10.8 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Return of Product Rights
Apr 10, 2014
PDF 13.8 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Present at the 26th Annual ROTH Conference
Mar 5, 2014
PDF 10.7 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2013 Financial Results
Mar 3, 2014
PDF 20.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host 2013 Financial Results Conference Call on March 4, 2014
Feb 18, 2014
PDF 10.5 KB Add to Briefcase
View Summary Acura Pharmaceuticals Secures $10.0 Million of Debt Financing
Dec 30, 2013
PDF 13.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals Provides Update on Its Abuse Deterrent Hydrocodone/Acetaminophen Combination Drug Development
Dec 9, 2013
PDF 15.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Third Quarter 2013 Financial Results
Nov 4, 2013
PDF 21.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Distribution of Nexafed(R) by Rite Aid Pharmacies
Nov 4, 2013
PDF 12.8 KB Add to Briefcase
View Summary Acura Pharmaceuticals to Host Third Quarter 2013 Financial Results Conference Call on November 5, 2013
Oct 29, 2013
PDF 10.6 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Settlement of Oxecta(R) Patent Litigation With Par Pharmaceutical and Impax Laboratories
Oct 9, 2013
PDF 15.8 KB Add to Briefcase
View Summary Acura Pharmaceuticals Provides Update on NEXAFED(R) Launch
Sep 18, 2013
PDF 14.2 KB Add to Briefcase
View Summary Research Confirms New Nasal Decongestant Product Is Highly Meth-Resistant Yet Offers Same Effectiveness as Leading Pseudoephedrine Brand
Sep 3, 2013
PDF 16.3 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Top-Line Results of a Clinical Study Assessing Abuse Liability
Aug 26, 2013
PDF 17.9 KB Add to Briefcase
View Summary Acura Pharmaceuticals Announces Second Quarter 2013 Financial Results
Aug 1, 2013
PDF 22.0 KB Add to Briefcase
Showing 1-20 of 67 Page: 1 2 3 4  Next 20
Add to Briefcase = add release to Briefcase